The mechanism of bacteriophage DNA injection is poorly understood, often considered a simple process, driven merely by the packing pressure inside the capsid. In contrast to the well-established DNA packaging mechanism of Bacillus subtilis phage Ø29, that involves a molecular motor formed by the connector and a viral ATPase, nothing is known about its DNA injection into the cell. We have studied this process measuring DNA binding of p6, a viral genome organization protein. The linear DNA penetrates with a right-left polarity, in a two-step process. In the first step ~ 65% of the genome is pushed into the cell most probably by the pressure built inside the viral capsid. Thus, synthesis of viral proteins from the right early operon is allowed. This step is controlled, probably by bacterial protein(s) that slow down DNA entry. In the second step at least one of the viral early proteins, p17, participates in the molecular machinery that pulls the remaining DNA inside the cell. Both steps are energy-dependent, as treatment of cells with azide overrides the whole mechanism, leading to a deregulated, passive entry of DNA.
Introduction
Bacteriophages are the most abundant group of biological entities in the biosphere (Bergh et al ., 1989; Danovaro et al ., 2001; Rohwer and Edwards, 2002; Rohwer, 2003) . Most phages are host-specific and only infect certain species or even strains of bacteria. Bacteriophage infection follows the same general scheme: the phage first binds reversibly to the cell surface; then, it recognizes and binds specifically its receptor, and then DNA is released from the capsid and injected into the cytoplasm. However, although a key step in the phage development, we still have a poor understanding of the molecular mechanisms of phage infection.
Tailed bacterial viruses are especially efficient in their ability to infect their hosts, and they are the most studied ones. A signal has to be transmitted from the receptor binding site of the tail to the connector or the baseplate, triggering its opening to allow the DNA ejection. It is generally believed that the energy required for DNA ejection from the head is provided mainly by the DNA pressure built inside the capsid, in which is spooled in a quasicrystalline packing (Cerritelli et al ., 1997) . However, this often considered a simple mechanism is far more complex, as there is not a unique way for DNA injection, and different phages follow different strategies. Thus, in Escherichia coli phage l it is thought that the DNA enters the cell by diffusion (Filali Maltouf and Labedan, 1985) . In phage T4, that has a contractile tail and a cell-puncturing device in the baseplate whose structure has recently been solved at 2.9 Å resolution (Kanamaru et al ., 2002) , the 169 kb genome is ejected in 30 s, the highest rate observed for DNA transport, crossing the cytoplasmic membrane through ion channels requiring the presence of the protonmotive force (Boulanger and Letellier, 1988; Letellier and Boulanger, 1989) . However, phage T7, with a much smaller genome (40 kb) than T4 requires between 9 and 12 min, and is the only system described for which DNA ejection is coupled to transcription (reviewed in Molineux, 2001) . The initial 850 bp of bacteriophage T7 genome are first delivered into the cytosol by an ejection mechanism (García and Molineux, 1996) in which it has been proposed that a molecular motor formed by viral proteins gp16 and gp15 controls the amount of DNA that enters the cell (reviewed in Molineux, 2001 ). The DNA penetrated includes promoters A1, A2 and A3, recognized by the E. coli RNA polymerase. Then, E. coli RNA polymerase pulls up to ~ 7 kb of the T7 genome, that comprise the T7 RNA polymerase gene and several T7 promoters. T7 RNA polymerase drags the remainder of the genome into the cell. Thus, transcription provides the driving force for the entry of most of the genome; in fact, using laser tweezers, it has been demonstrated that a transcribing RNA polymerase is a strong and efficient molecular motor (Wang et al ., 1998) . Phage T5 DNA (121 kb) is transferred in two steps: 8% of the DNA is first transferred to the cytoplasm (Lanni, 1968) . Then, there is a pause of about 4 min during which two proteins (A1 and A2) encoded by this fragment are synthesized. The transfer of the remaining DNA takes place only if these proteins have been synthesized (reviewed in Letellier et al ., 1999) . Although the mechanism by which they carry out the transfer is not known, it has been suggested that the DNA binding protein A2 pulls the DNA (Letellier et al ., 2003) .
The non-contractile tail Bacillus subtilis phage Ø29 has a 19 kb linear DNA and has been extensively studied, in particular its DNA replication and transcription program (reviewed in Meijer et al ., 2001a) , as well as the packaging mechanism (reviewed in Grimes et al ., 2002) . The highly efficient in vitro Ø29 DNA-packaging system has allowed to understand in great detail this process, in which a rotary motor translocates unidirectionally the DNA into a preformed capsid precursor called the prohead. This motor contains three essential components: the connector, the ATPase and the pRNA. The head-tail connector is a 12-fold oligomer of protein p10, the structure of which has been solved by X-ray diffraction (Simpson et al ., 2000; Guasch et al ., 2002) and suggests a translocation mechanism in which the longitudinal displacement of the DNA along its axis is coupled to connector spinning (Guasch et al ., 2002) . A more complex model was proposed, implying a domain displacement within the p10 protomers, and a spring-like elongation and contraction of the connector length (Simpson et al ., 2000) . Packing of DNA into proheads during morphogenesis is an ATP-driven process, in which Ø29 protein p16 bears the ATPase activity (Guo et al ., 1987a) , that requires pRNA (Grimes and Anderson, 1990) . The pRNA is a 174 nt RNA coded from the left end of the genome that forms a ring required for translocation and probably provides the specificity of the packaging polarity (Guo et al ., 1987b;  for review see Guo, 2002) . The in vitro packaging system has allowed, using optical tweezers, to measure the forces involved in the packaging of a single Ø29 DNA molecule into an isolated prohead, resulting in one of the strongest molecular motors reported to date, with an average stalling force of 57 pN and an initial speed of 100 bases per second under external load (Smith et al ., 2001) ; therefore, the high internal pressure built up, estimated to be roughly 6 MPa (60 atmospheres), is suggested to provide the driving force for DNA injection into the host cell for the first half of the process (Smith et al ., 2001) .
The great wealth of data about Ø29 DNA packaging is in great contrast to the lack of information about the DNA entry into the host cell. Spontaneous release of Ø29 DNA from 12 -
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-defective viral particles showed a right to left polarity (Krawiec et al ., 1981) . Indeed, the opposite orientation was observed in an in vitro DNA packaging system in which the left end is packaged first (Bjornsti et al ., 1983) . Therefore, it is assumed that the right DNA end enters the cell first. In this work we have monitored Ø29 DNA entry into the cell by binding of viral protein p6 to the whole Ø29 DNA in vivo , analysed by cross-linked chromatin immunoprecipitation (X-ChIP) and real-time PCR (V. González-Huici, unpublished data). We show that Ø29 DNA injection is a finely regulated two-step process. In the first step the right half of the phage genome gets into the cell, propelled by the packing pressure of DNA into the capsid, whereas penetration of the left half requires synthesis of viral proteins, at least protein p17, and an external energy source.
Results

Phage Ø29 DNA injection is a two-step process that requires viral protein synthesis
Phage Ø29 protein p6 is an architectural protein that binds along the whole linear Ø29 DNA, although its binding to both DNA ends is higher than to the internal regions, being the affinity for the left end higher than for the right one (V. González-Huici, unpublished data). We have taken advantage of these features to monitor the entrance of Ø29 DNA into the host cell during the process of viral injection by protein p6 binding. For this, we have used a B. subtilis strain harbouring a plasmid that constitutively expresses protein p6 (Bravo et al ., 1994) infected with phage Ø29 sus14 (1242), a delayed lysis mutant (Jiménez et al ., 1977) , with otherwise wild-type phenotype. This p6-producing strain allows a normal phage development, although the DNA replication onset and the infective particles production are delayed 15-20 min (Bravo et al ., 1994; and our unpublished results) . Protein p6 binding to six Ø29 DNA regions was measured by X-ChIP and real-time PCR. These regions are scattered through the genome as depicted in Fig. 1A , where L and R stands for the left and right terminal regions, respectively, and 5.1, 7.4, 9.7 and 11.7 stands for their distance (in Kb) from the left end. Infected cells were treated with novobiocin 10 min before cross-linking, as it increases the p6 binding by approximately 30-fold (V. González-Huici, M. Alcorlo, M. Salas and J. M. Hermoso, in preparation). Protein p6-producing cells were infected with Ø29 sus14 (1242) (moi 3), and cross-linking performed at the times indicated, adding 500 m g ml -1 novobiocin 10 min before. The IC data for the six DNA regions studied (Fig. 1A) are shown for each infection time.
to the Ø29 DNA regions, measured at different times after infection and expressed as immunoprecipitation coefficient (IC, see Experimental procedures ). As expected, protein p6 binding at a particular region increased with the time; furthermore, at any particular time, except for the last one, the values obtained from the right end region are higher than those from the left one. These results clearly show that the polarity of injection is from right to left. At the latter time, DNA replication is already started, so p6 binding data are reflecting both input and replicated DNA. Thus, this latter time cannot be used for the injection studies.
Interestingly, under these conditions, in protein p6-producing cells, left end entrance seems to be impaired with respect to non-producing ones, in which protein p6 is synthesized during infection. When, in these Ø29-infected cells, we add novobiocin and chloramphenicol 10 min after infection, performing the cross-linking 20 min after infection, p6 binding at L (IC = 2055) was almost twice than to R (IC = 1144) (not shown). However, as shown in Table 1 , in p6-producing cells binding to R (IC = 4398) was more than 10-fold than to L (IC = 312). In both cases replication has not started, so the data are comparable. Protein p6 is known to repress transcription from early promoter C2 (Whiteley et al ., 1986; Barthelemy et al ., 1989; Camacho and Salas, 2000) located about 200 bp away of the right end of Ø29 DNA (see Fig. 1A ). Thus, the delay observed in p6-producing cells could be explained by the repression of promoter C2, suggesting that one or more proteins coded by this operon could be involved in injection.
To determine if synthesis of viral proteins is required for injection of the left end of the Ø29 genome, we infected p6-producing cells in the presence of chloramphenicol (CM), performing the cross-link 10 or 40 min later. As shown in Fig. 1B , again the right to left polarity of infection is clearly observed. Penetration of the right ~ 65% of the genome does not require viral proteins; however, p6 binding to the left end is negligible even after 40 min post infection, binding values being about 1% of those to the right end. This indicates the absolute requirement of newly synthesized viral protein(s) for injection of the left side of Ø29 DNA.
To further study the viral protein synthesis requirement, we added CM at different times after infection. Figure 2 shows that p6 binding to all regions increases with the 
Viral protein p17 is necessary for efficient internalization of the left side of Ø29 DNA
The injection of the left side of Ø29 DNA requires at least an early protein expressed from promoter C2, located at the right side of the genome. Promoter C2 controls an operon that encodes four gene products: p16.7, p16.8, p16.9 and p17, of which only p16.7 and p17 have been studied (reviewed in Meijer et al ., 2001a) . Protein p16.7 has been proposed to serve as anchoring point of viral DNA to the membrane (Meijer et al ., 2000; 2001b; SernaRico et al ., 2002; 2003) and protein p17 has been shown to be necessary in vivo for efficient DNA replication (Carrascosa et al ., 1976; Crucitti et al ., 1998) and in vitro enhances the protein p6 binding to DNA (Crucitti et al ., 2003) . To study the possible effect of these proteins in injection, we followed the viral DNA entrance in p6 producing-cells infected with the double mutant Ø29 sus16.7 (48)/ sus14 (1242) (Meijer et al ., 2001b) and single mutant Ø29 sus17 (112) (Moreno et al ., 1974) , taking as control the single mutant Ø29 sus14 (1242). Cells were crosslinked at the indicated times post infection, adding CM and novobiocin 10 min before, and binding to Ø29 DNA left (L) and right (R) ends was measured. As shown in Fig. 3A and B, although the total binding in cells infected with sus16.7 (48)/ sus14 (1242) was lower than in those infected with sus14 (1242), the relative binding to L with respect to R was only barely decreased, being the injection pattern essentially the same in both cases. On the contrary, the injection pattern changed in Ø29 sus17 (112)-infected cells, being the binding to L specifically impaired with respect to R (Fig. 3C ). There is an overall lower p6 binding to both L and R, particularly at late infection times, that could be the result of the impairment in DNA replication and protein p6 binding described for this mutant (Crucitti et al ., 1998; 2003) . The impairment of penetration of L in sus17 (112)-infected cells is more clearly seen in Fig. 3D , which shows the ratio of p6 binding to L over R for the three mutants. The L/R binding ratio begins to increase at 25-30 min post infection for sus14 (1242) and sus16.7 (48)/ sus14 (1242), with a slight delay for the latter. However, the L/R binding ratio for sus17 (112) (1242) it is detected 40-45 min post infection (not shown). The lack of DNA replication has no effect on the L/R binding ratio, as the same result was essentially obtained with the replication deficient mutant sus3 (91) as with sus14 (1242) (not shown). The requirement of protein p17 for the second step of Ø29 DNA injection was confirmed by an entirely different experimental approach: the determination of the kinetic of synthesis of proteins from the right and left sides of the genome. Gene 16.7 is transcribed from promoter C2, at the right genome end, and is injected in the first step. Gene 6 is on the left operon, transcribed from promoters A2b and A2c (position ~ 5 kb; see Fig. 1A ), so it is injected in the second step. For these experiments we used B. subtilis cells non-producing p6, instead of the p6-producing strain used in all the other experiments. These cells were infected with Ø29 sus17 (112), and protein synthesis was analysed by Western blot 10, 15 and 20 min later. We used as control the Ø29 sus3 (91) mutant to ensure that, as with sus17 (112) mutant, no DNA replication takes place at the times studied. Figure 4 shows that the amount of protein p6 synthesized in Ø29 sus3 (91)-infected cells is higher than that from sus17 (112)-infected cells. Therefore, expression of genes from the left side of the genome is impaired in a Ø29 sus17 mutant, in agreement with a requirement of protein p17 for the second step of injection. The higher amount of p16.7 in sus17 (112)-infected cells with respect to sus3 (91)-infected cells again reflects the delayed injection of the gene 6-containing left end. The reduced amount of p6 cannot efficiently repress the C2 promoter.
The mechanism of DNA injection is energy-dependent
Although the first step of Ø29 DNA injection does not require the synthesis of viral proteins, and apparently depends only on the release of the potential energy accumulated in the DNA inside the capsid, the second step could probably require an external energy source. Thus, we studied p6 binding to Ø29 DNA left end in protein p6-producing cells infected with Ø29 sus14 (1242) in the presence of 20 mM sodium azide, that dissipates the membrane potential and deprives cells of energy. As shown in Fig. 5A , azide impairs p6 binding to L, indicating that efficient internalization of the left end indeed requires energy. To analyse the possible relation of p17 with this energy requirement we studied the effect of azide in Ø29 sus17 (112)-infected cells. Surprisingly, in this case azide increased p6 binding to L about sevenfold (Fig. 5B) , reaching a level comparable to that of azide-treated cells infected with sus14 (1242) 40 min after infection (Fig. 5A) . If p17 is part of a hypothetical molecular motor that controls the injection process at the expense of energy, deenergization of the cell would override the motor and allow a passive, uncontrolled DNA entry. When we added azide at the infection time in the presence of CM, in which, as shown before, the entry of the left side of DNA is absolutely prevented (see Fig. 1B ), binding to L dramatically increases (Fig. 5C ). This effect is comparable to that observed in Ø29 sus17 (112)-infected cells and again the blockage of the entrance of the left part of the DNA is bypassed, allowing a deregulated, passive injection.
We also studied whether addition of azide has any effect on the first step of injection, when no viral proteins are involved. Curiously enough, we found an increase of p6 binding to the right end of DNA in sus14 (1242)-infected cells, either at 10 or 40 min post infection (Fig. 5D ), suggesting the existence of an energydependent bacterial mechanism that regulates the penetration of the right end of DNA. Altogether, these results strongly suggest that both steps of Ø29 DNA injection are regulated by a protein network that requires energy and is disabled by de-energization of cells, allowing a passive and less efficient DNA entry.
Discussion
In this paper we have studied the process of injection of bacteriophage Ø29 DNA, monitoring the viral DNA entrance by the binding of protein p6, that organizes the Ø29 genome in vivo (V. González-Huici, unpublished data). Protein p6 binding was measured by X-ChIP and the immunoprecipitated DNA quantified by real-time PCR; thus, the amount of a particular region of Ø29 DNA inside the cell can be accurately measured. With this approach we have determined that the polarity of the viral DNA penetration is from right to left, in agreement with the packaging studies that show an inverse polarity (Bjornsti et al., 1983) . Furthermore, we have found that the injection of Ø29 DNA is a two-step process: the right side would enter first at the expense of the packaging pressure of DNA in the capsid, whereas entrance of the left hand side, prevented by CM, would require viral protein(s). These results are in agreement with recent studies of Ø29 DNA packaging in vitro using optical tweezers, which demonstrate that up to ~40% of DNA can be packaged at a very low energy cost; however, from this point on, the force necessary to drive DNA into the capsid grows exponentially (Smith et al., 2001 ). When we add CM after infection, the amount of injected left end increases with the time allowed for protein synthesis, until 40 min when the p6 binding follows the same pattern as in the absence of CM (V. González-Huici, unpublished data). The protein(s) involved in the second step of injection are likely synthesized from the C2 operon, located at the very right end of the viral genome (see Fig. 1A ), as C2 is the main early promoter available to B. subtilis RNA polymerase at the right Ø29 DNA end. As promoter C2 is repressed in vivo by protein p6 (Whiteley et al., 1986) , completion of the ) and novobiocin (500 mg ml -1 ) were added at the indicated times. Cross-linking was performed at the indicated infection times. injection process is delayed in p6-producing cells at least 20 min with respect to a non-producing strain. In agreement with this, as the genes of the main replication proteins are transcribed from the early promoters A2b and A2c, located at 5.1 kb from the left end (see Fig. 1A ), the DNA replication onset, as measured by real-time PCR, is also delayed 20 min in cells that express protein p6 (M. Alcorlo, unpublished data).
The injection apparatus should include at least one protein from the right C2 operon that expresses proteins p16.7, p16.8, p16.9 and p17 (Meijer et al., 2001a) . Protein p17, described to be required for efficient viral DNA synthesis in vivo (Crucitti et al., 1998) , plays a central role in the second step of the injection process. First, in cells infected with a sus mutant in gene 17 protein p6 binding to the left end is drastically decreased. As the absence of protein p17 has no effect on the intrinsic affinity of p6 for the left end relative to the right one, this result can be explained only by a delayed penetration of the left end. Second, the synthesis of proteins from the left operon (e.g. p6), with respect to those from the right operon (e.g. p16.7) at early infection times is clearly reduced in sus17 (112)-infected cells in comparison with sus3 (91)-infected cells. However, other viral proteins, in addition to p17, seem to be required for an efficient injection. Although the penetration of the left part of the genome is highly impaired in a sus17 (112)-infected cell, it is still higher than that of CM-treated cells, in which no injection of the left end can be detected. In addition, it is higher when sus17 (112) mutant phage infects a cell non-producing p6 than a p6-producing one, in which the C2 promoter is repressed. Protein p16.7, proposed to anchor Ø29 DNA to the membrane and organize its replication (Serna-Rico et al., 2003) does not seem to be involved, as the observed injection delay in sus16.7 (48)-infected cells is very small. Thus, proteins p16.8 and p16.9, whose function is still unknown, arise as potential candidates to take part in the injection machinery that would pull the left side of Ø29 DNA into the cytoplasm. A model of the Ø29 DNA injection mechanism is outlined in Fig. 6 .
The two-step mechanism of injection allows us to envisage a scenario in which Ø29 DNA is transcribed in three stages: very early, early and late. In the very early transcription, when only the right side of Ø29 DNA is injected, promoter C2 is the main viral promoter available for the host RNA polymerase, allowing the synthesis of proteins, such as p17, involved in pulling the left side of DNA into the cell. In the early transcription, the injection is completed and the left early operon is transcribed from promoters A2b and A2c, giving rise to the main replication proteins, DNA polymerase (p2), terminal protein (p3), SSB (p5) and p6 (Fig. 1A) . The latter, besides its role in DNA replication, switches off very early transcription from promoter C2 (Whiteley et al., 1986; Barthelemy et al., 1989) . Late transcription begins when a sufficient amount of proteins p6 and p4, both transcribed from the early promoters A2b and A2c, is attained; then, they inhibit early transcription from pA2b and A2c and trigger transcription from the late promoter A3 (Elías-Arnanz and Salas, 1999) giving rise to structural, morphogenetic, and lytic proteins (Fig. 1A) .
We have studied the energetic requirements for Ø29 DNA injection measuring p6 binding to both DNA ends in cells infected in the presence of azide, showing that both steps of injection are energy-dependent. Addition of azide enhanced the first step, suggesting the existence of protein(s) that control the entry of the right end. These proteins would most probably be bacterial, as no viral proteins have been described to be delivered into the cell together with DNA, except the covalently linked terminal protein; however, we can not rule out that any structural protein of the phage is involved. DNA injection of phages, such as T1, T4, T5 and T7, is described to increase the membrane permeability (Boulanger and Letellier, 1988; 1992; Letellier and Boulanger, 1989) . Therefore, it is presumable that Ø29 DNA enters the cell through a channel formed by host proteins. Although more data are required to elucidate the injection mechanism, the simplest model is that the penetration of the right part of the Ø29 genome, driven by its high internal force in the virion (~50 pN; Smith et al., 2001) , could be slowed down by a narrowing of the channel, regulated by a proton-motive force and/or ATP hydrolysis. Alternatively, there could be a cytoplasmic bacterial protein that would clamp the DNA at the expense of energy. In any case, this controlled entry may be relevant to optimize expression levels of the C2 operon proteins. In energy-deprived cells the control of DNA entry would be prevented, leading to a deregulated penetration of Ø29 DNA. In the case of E. coli phage T5, that also injects its DNA in two steps, depletion of metabolic energy does not affect first-step transfer (Filali Maltouf and Labedan, 1983) . However, in the case of phage T4 the channel is closed and DNA penetration prevented (Boulanger and Letellier, 1988) .
In contrast, azide significantly impairs the second step of Ø29 DNA injection. This seems reasonable as the penetration of the left part of the genome probably requires a hypothetical energy-consuming molecular motor to pull the remaining DNA inside the cell, as wheñ 60% of the genome is ejected from the capsid the internal force drops to zero (Smith et al., 2001) . Viral proteins of the C2 operon, at least p17, would be constituent of this hypothetical motor that could be energized by a host ATPase (no viral enzyme has been described to play this role), or an electrochemical gradient. As the motor would not function in energy-deprived cells, the entrance of the left part of the genome is impaired, but not completely aborted, suggesting that a passive, less efficient, mecha-nism of injection is also possible. However, when the injection machinery is incomplete, as is the case of sus17 (112)-infected or CM-treated cells, but energy is available, left DNA end penetration is prevented to a much higher extent. This means that bacterial protein(s) halt DNA entry, keeping DNA stalled until the viral proteins required for injection have been synthesized. When the injection machinery is disabled through de-energization, DNA trapping, either by a closed channel or by interaction with other protein(s), would be avoided and therefore the left end would entry by the passive mechanism. A similar situation is described for phage T5, although disabling the injection machinery is not known to be necessary for T5 DNA to enter the cell by a passive mechanism (Boulanger and Letellier, 1992) .
In conclusion, the results presented in this paper indicate that the injection of Ø29 DNA is a two-step process, apparently controlled by an active transport mechanism formed by viral and bacterial proteins (see Fig. 6 ). In the first step, about 60% of the right side of Ø29 DNA is pushed into the cytoplasm, most probably by the packaging pressure built inside the capsid. This process would be probably controlled by an energy-consuming bacterial system. The internalized DNA exposes the early rightmost promoter C2 from which proteins involved in the second step of injection are expressed, among them protein p17. They would form the machinery that pulls the left part of the viral DNA into the cytoplasm. If any piece of the motor is lacking, the entrance of the left part of the DNA is prevented; however, energy depletion would override the . Model for bacteriophage Ø29 DNA injection. Scheme of the 'push-pull' mechanism of Ø29 DNA entry into the cell. Once the phage recognizes its entry site in the membrane (left), pushes about 65% of its rightmost DNA into the cytoplasm at the expense of the packaging pressure inside the capsid (middle). Next, expression of the early promoter C2, at the right end of Ø29 DNA, gives rise to at least four proteins, p16.7, p16.8, p16.9 and p17. For the second step of injection (right), assembly of a multiprotein complex is required to pull the remaining DNA into the cell. Protein p17 (dark ellipse) would be required for this second step, p16.7 (in white) does not seem to participate, and p16.8 and/or p16.9 (dotted ellipses) could be involved, although no evidence is still available. If chloramphenicol (CM) is added, no viral proteins are synthesized and therefore the second step of the injection is absolutely prevented. Bacterial protein(s) (dotted square), could also be necessary, at least to provide the energy required for the process, either from ATP hydrolysis and/or an electrical (Dy) or proton (DpH) gradient (see Text for details).
control of the injection, allowing DNA to enter the cell by simple diffusion. The results presented in this paper open many interesting questions about this hypothetical motor. The characterization of proteins p16.8 and p16.9 will shed light on the viral component of the machinery. The determination of the energy source, an electrochemical potential or ATP, may be addressed by the use of specific inhibitors (as uncouplers, ionophores, oligomycin or arsenate), and may give valuable clues on the bacterial protein(s) involved in internalization of the left part of the Ø29 genome.
Experimental procedures
Bacteria, plasmids and phages
We used a B. subtilis 110NA strain (trpC2, spoOA3, su -) (Moreno et al., 1974) , harbouring plasmid pPR55w6, a pUB110-derivative containing Ø29 gene 6 (Bravo et al., 1994) , except where indicated. Infections were carried out with phage Ø29 sus14 (1242), a delayed lysis mutant with an otherwise wild-type phenotype (Jiménez et al., 1977) , sus3 (91) a replication-null mutant, sus17 (112) (Moreno et al., 1974) or sus16.7 (48)/sus14 (1242) (Meijer et al., 2001b) , replication-defective mutants. Bacteria were grown in LB broth supplemented with 5 mM MgSO 4 . Phleomycin, from Cayla SARL, was added to the medium at a final concentration of 0.8 mg ml -1 .
Enzymes, drugs and reactives
Micrococcal nuclease was from Amersham Pharmacia Biotech and proteinase K from Boehringer Mannheim. Protein A-Sepharose CL-4B, lysozyme, RNase A, chloramphenicol and novobiocin, were from Sigma. Formaldehyde at 37% was purchased to Calbiochem. Sodium azide was from Merck.
DNAs and oligonucleotides
Proteinase K-digested Ø29 DNA was obtained as described (Inciarte et al., 1976) . The sequences of the oligonucleotides used for PCR (Isogen) are given below, together with the coordinates of the DNA sequence they amplify, Ø1 to Ø6; U: upper strand; L: lower strand.
Cross-linking, immunoprecipitation and DNA amplification X-ChIP was performed essentially as described (Lin and Grossman, 1998) with slight modifications. Bacteria were grown at 30∞C up to 10 8 cells ml -1 and infected at a multiplicity of infection (moi) of 3. Chloramphenicol and/or novobiocin were added at the indicated times, and except where noted, bacteria were allowed to grow for 10 additional min before cross-linking. Culture samples, 20 ml each, were treated directly with 1% formaldehyde, together with 10 mM sodium phosphate, pH 7.2. After 5 min at room temperature without shaking, reactions were stopped by addition of 125 mM glycine. Cells were harvested by centrifugation, washed twice with PBS buffer and resuspended in 1 ml of buffer A (10 mM Tris-HCl, pH 8.0, 50 mM NaCl, 10 mM EDTA), with 3 mg ml -1 lysozyme. Samples were incubated for 30 min at 37∞C before lysis by addition of 1 ml of 2 ¥ IP buffer (100 mM TrisHCl, pH 7.0, 300 mM NaCl, 2% Triton X-100) and 0.1% SDS. Then, samples were subjected to mild digestion with micrococcal nuclease (0.05 U in the presence of 13 mM CaCl 2 ) for 10 min at 37∞C, stopping reactions with 20 mM EDTA. DNA was sheared to an average size of 750 bp by sonication and cell debris eliminated by centrifugation. 1/20 of each sample was kept for total DNA analysis (T sample) and the remaining was split to immunoprecipitate with either ap6 polyclonal antibodies (ap6 sample) or preimmune serum (pi sample) (20 ml each) overnight at 4∞C, followed by incubation for 2.5 h at 4∞C with 60 ml of a 25% protein A-Sepharose slurry. Complexes were collected by centrifugation and washed twice with 1 ¥ IP-0.1% SDS buffer, three times with 1 ¥ IP buffer and twice with TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA). The slurry was resuspended in 150 ml of TE buffer containing 1% SDS to disrupt immune complexes. Total DNA samples were also brought to a total volume of 150 ml TE containing 1% SDS. All samples were incubated overnight at 65∞C with shaking to reverse cross-links. Slurry was removed by centrifugation and the supernatant transferred to a fresh tube. DNA was purified by phenol:chloroform extraction, ethanol-precipitated and finally resuspended in water.
Analysis of DNA samples was performed by real-time PCR in a Light-Cycler instrument using a 'Light Cycler-FastStart DNA Master SYBR Green I' hot-start reaction mix (Roche). Although the sequences amplified are 212-363 bp in length, the results are representative of a much wider region, as the average size of the DNA fragments that contain these sequences is 750 bp. This means 750 bp for regions L and R, at both ends of the genome, and 1200 bp for the internal regions 5.1-11.7. The data obtained for each region were interpolated to a standard curve constructed with known amounts of purified, full-length, Ø29 DNA. The results were expressed as pg of Ø29 DNA per ml of culture. Binding values are expressed as immunoprecipitation coefficient or IC: [(ap6-pi)/T] ¥ 10 6 . The amplification conditions included a preheating step of 20 min at 95∞C to activate the polymerase, followed by 30 cycles comprising a denaturation step of 15 s at 95∞C for all regions, a hybridization step of 5 s at 53∞C for regions L and 11.7, 5 s at 50∞C for R, 10 s at 51∞C for 7.4 and 9.7, and 10 s at 48∞C for 5.1, and an elongation step at 72∞C lasting 15 s for L and 11.7, 40 s for R, 30 s for 7.4 and 9.7, and 60 s for 5.1. Finally, a melting analysis was performed by continuous fluorescence measurement from 65∞C to 95∞C, to check that a single product was amplified. Primer hybridization to bacterial DNA was previously ruled out in a control with uninfected cells.
Western blot analysis
Cells were grown at 30∞C to 10 8 ml -1 and infected. At the time indicated, 5 ml aliquots were transferred to an ice-cold tube, concentrated 20-fold in loading buffer (60 mM Tris-HCl, pH 6.8, 2% SDS, 5% b-mercaptoethanol, 30% glycerol) and disrupted by sonication. Aliquots of the cell extract were subjected to SDS-PAGE on a 15% polyacrylamide gel. After electrophoresis, proteins were transferred using a Mini Trans Blot apparatus (Bio-Rad) at 100 mA and 4∞C, for 45 min to detect protein p16.7 and 60 min to detect protein p6. Immobilon-P membranes (Millipore) were probed with either antip16.7 or anti-p6 polyclonal antibodies (diluted 1:2500 and 1:2000, respectively) for 70 min. Then, membranes were incubated with anti-rabbit horseradish peroxidase-conjugated antibodies (diluted 1:4000) for 70 min, and the immune complexes detected by ECL detection reagents (Amersham). Films were scanned and bands subjected to densitometry using an Image Quant software.
